Market closed

Enzo Biochem/$ENZ

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Enzo Biochem

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Ticker

$ENZ
Sector
Health Care

Trading on

NYSE

Industry

Health Care Providers & Services
Headquarters
Farmingdale, United States

Employees

131
Website
www.enzo.com

Enzo Biochem Metrics

BasicAdvanced
$35M
-
-$0.45
0.80
$0.10
60.21%

$35M

0.8

$1.44

$0.65

187K

$0.10

2.55

2.204

4.96

6.855

-52.35%

-7.24%

-11.83%

1.127

0.73

0.73

-1.51

15.05%

60.21%

-4.57%

-191.65%

-35.99%

65.27%

Enzo Biochem Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Enzo Biochem Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Enzo Biochem News

AllArticlesVideos
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules

Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules

GlobeNewsWire·7 hours ago
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update

Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update

GlobeNewsWire·4 weeks ago
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend

Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend

GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ENZ

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Enzo Biochem stock?

Enzo Biochem (ENZ) has a market cap of $35M as of January 15, 2025.

What is the P/E ratio for Enzo Biochem stock?

The price to earnings (P/E) ratio for Enzo Biochem (ENZ) stock is 0 as of January 15, 2025.

Does Enzo Biochem stock pay dividends?

Yes, the Enzo Biochem (ENZ) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $0.1 and the yield is 60.21%. Enzo Biochem has a payout ratio of 0% on a trailing twelve-month basis.

When is the next Enzo Biochem dividend payment date?

The next Enzo Biochem (ENZ) dividend payment date is unconfirmed.

What is the beta indicator for Enzo Biochem?

Enzo Biochem (ENZ) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.